Gansevoort RT - Search Results

1

Macroalbuminuria is a better risk marker than low estimated GFR to identify individuals at risk for accelerated GFR loss in population screening.

Halbesma N, Kuiken DS, Brantsma AH, Bakker SJ, Wetzels JF, De Zeeuw D, De Jong PE, Gansevoort RT. Halbesma N, et al. Among authors: gansevoort rt. J Am Soc Nephrol. 2006 Sep;17(9):2582-90. doi: 10.1681/ASN.2005121352. Epub 2006 Aug 9. J Am Soc Nephrol. 2006. PMID: 16899519

2

Antiproteinuric drugs in patients with idiopathic membranous glomerulopathy.

Gansevoort RT, Heeg JE, Vriesendorp R, de Zeeuw D, de Jong PE. Gansevoort RT, et al. Nephrol Dial Transplant. 1992;7 Suppl 1:91-6. Nephrol Dial Transplant. 1992. PMID: 1337189

3

The antiproteinuric effect of antihypertensive agents in diabetic nephropathy.

Gansevoort RT, Apperloo AJ, Heeg JE, de Jong PE, de Zeeuw D. Gansevoort RT, et al. Arch Intern Med. 1992 Oct;152(10):2137-9. Arch Intern Med. 1992. PMID: 1417388 No abstract available.

4

Sodium depletion enhances the antiproteinuric effect of ACE inhibition in established experimental nephrosis.

Gansevoort RT, Wapstra FH, Weening JJ, de Jong PE, de Zeeuw D. Gansevoort RT, et al. Nephron. 1992;60(2):246-7. doi: 10.1159/000186753. Nephron. 1992. PMID: 1553017 Free article. No abstract available.

5

Additive antiproteinuric effect of ACE inhibition and a low-protein diet in human renal disease.

Gansevoort RT, de Zeeuw D, de Jong PE. Gansevoort RT, et al. Nephrol Dial Transplant. 1995;10(4):497-504. doi: 10.1093/ndt/10.4.497. Nephrol Dial Transplant. 1995. PMID: 7623991 Clinical Trial.

6

Losartan in patients with renal insufficiency.

de Zeeuw D, Gansevoort RT, de Jong PE. de Zeeuw D, et al. Among authors: gansevoort rt. Can J Cardiol. 1995 Aug;11 Suppl F:41F-44F. Can J Cardiol. 1995. PMID: 7664217

7

Effects of the angiotensin II antagonist losartan in hypertensive patients with renal disease.

Gansevoort RT, de Zeeuw D, Shahinfar S, Redfield A, de Jong PE. Gansevoort RT, et al. J Hypertens Suppl. 1994 Jul;12(2):S37-42. J Hypertens Suppl. 1994. PMID: 7965264 Clinical Trial.

8

Symptomatic antiproteinuric treatment decreases serum lipoprotein (a) concentration in patients with glomerular proteinuria.

Gansevoort RT, Heeg JE, Dikkeschei FD, de Zeeuw D, de Jong PE, Dullaart RP. Gansevoort RT, et al. Nephrol Dial Transplant. 1994;9(3):244-50. Nephrol Dial Transplant. 1994. PMID: 8052429

9

Is the antiproteinuric effect of ACE inhibition mediated by interference in the renin-angiotensin system?

Gansevoort RT, de Zeeuw D, de Jong PE. Gansevoort RT, et al. Kidney Int. 1994 Mar;45(3):861-7. doi: 10.1038/ki.1994.113. Kidney Int. 1994. PMID: 8196289 Free article. Clinical Trial.

10

Dissociation between the course of the hemodynamic and antiproteinuric effects of angiotensin I converting enzyme inhibition.

Gansevoort RT, de Zeeuw D, de Jong PE. Gansevoort RT, et al. Kidney Int. 1993 Sep;44(3):579-84. doi: 10.1038/ki.1993.284. Kidney Int. 1993. PMID: 8231031 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

729 results

Search Page

Filters